Global Foot Drop Treatment Devices to Grow at a Substantial CAGR of 8.15% by 2027 | DelveInsight

The global Foot Drop Treatment Devices Market is anticipated to grow in the coming years owing to the rising prevalence of various knee-associated musculoskeletal disorders, growing cases of neuromuscular diseases, and rising geriatric population among other factors.

New York, USA, Nov. 24, 2022 (GLOBE NEWSWIRE) — Global Foot Drop Treatment Devices to Grow at a Substantial CAGR of  8.15% by 2027 | DelveInsight

The global Foot Drop Treatment Devices Market is anticipated to grow in the coming years owing to the rising prevalence of various knee-associated musculoskeletal disorders, growing cases of neuromuscular diseases, and rising geriatric population among other factors. 

DelveInsight’s “Foot Drop Treatment Devices Market” report provides the current and forecast market trends, forthcoming device innovation, key developments, challenges, major market drivers, barriers, market shares, ongoing developments, and key companies operating in the market. 

Key Takeaways from the Foot Drop Treatment Devices Market Report

  • As per DelveInsight’s assessment, among all the regions, North America is anticipated to account for the largest share in the year 2021 and will continue to dominate in the coming years owing to several favorable factors. 
  • The leading companies in the Foot Drop Treatment Devices Market include Ottobock, Bioness Inc., AxioBionics, Accelerated Care Plus Corporation, Saebo, Inc., Boston Orthotics & Prosthetics, Turbomed Orthotics, Össur, Thrive Orthopedics, Allard USA Inc., NextStep Robotics, Finetech Medical, Arthrex, Inc., Evolution Devices, Narang Medical Limited, SCHECK & SIRESS, AliMed, The London Orthotics Consultancy Ltd, Access Prosthetics, Spinal Solutions, and others.
  • In March 2022, Cionic announced FDA clearance for its leg-worn Cionic Neural Sleeve that provides functional electrical stimulation to assist in gait for people with foot drop and leg muscle weakness, including those with mobility issues due to multiple sclerosis (MS), stroke, cerebral palsy (CP) and other neurological conditions.
  • In September 2021, Evolution Devices announced the launch of its EvoWalk Platform pilot program to rehabilitate walking for people living with neurologically-based partial walking paralysis. Evolution Devices initially focused on rehabilitating Foot Drop, an impairment where a person is unable to lift their foot due to muscle weakness or nerve damage and which frequently causes falls.

To read more about the latest highlights related to the foot drop treatment devices market, get a snapshot of the key highlights entailed in the Foot Drop Treatment Devices Market Report 

Foot Drop Treatment Devices Overview

Foot drop, sometimes called drop foot, is not a disease but a condition in which the person faces difficulty in raising the front part of one or both feet. Some of the neurological, anatomical, or muscular problems can lead to Foot drop issues. Foot drops can occur due to underlying health conditions such as muscular sclerosis or stroke. 

Foot drops can be treated with orthotics such as ankle foot orthosis (AFO), rehabilitation with physical therapy, electrical nerve stimulation, or surgery. Treatment Devices such as braces, usually made of plastic, are called an “ankle-foot orthosis,” or AFO. The brace is worn around the lower leg and foot. It supports the ankle and holds both the foot and ankle flexibly. Similarly, an electrical stimulation device sends impulses to the muscles via surface electrodes that attach to the skin. This causes the muscles to contract and lift the foot. 

Foot Drop Treatment Devices Market Insights

Among all the regions, in 2021, North America accounted for the largest share of the Global Foot Drop Treatment Devices market. As per the assessment, North America will continue to dominate the Foot Drop Treatment Devices market during the forecast period from 2022-2027. Some of the key factors, such as the rising population of the elderly, an increasing number of neuromuscular diseases, and high awareness among patients and caregivers about different types of foot drop treatment devices and the ability to afford such devices, will stimulate the Foot Drop Treatment Devices market growth in the region.

Moreover, cases related to neurological disorders that lead to the weakening of limbs, like multiple sclerosis and exercise-related injuries, are on the rise in the US. As per the estimate, in the United States estimated, about one million people are living with Multiple Sclerosis. Foot drop, or drop foot, is a symptom of multiple sclerosis (MS) that leads to weakening limbs, among other symptoms. The rising cases of Multiple Sclerosis are anticipated to propel the Foot Drop Treatment Devices market growth. 

Additionally, the active presence of key players in the region, supportive reimbursement programs, and well-established patient care systems, along with awareness among patients and caregivers regarding different types of foot drop treatment devices, are also expected to have a positive impact on the North America foot drop treatment devices market growth.

Learn more about the key factors influencing the high demand and market growth in the North American region; Foot Drop Treatment Devices Market Trends and Developments

Foot Drop Treatment Devices Market Dynamics

The rising geriatric population who are prone to knee-associated musculoskeletal disorders is one of the key factors driving the demand for the Foot Drop Treatment Devices. As per estimates, in 2020, there were 727 million persons aged 65 years or over in the world, and the global number was projected to reach 1.5 billion by 2050. The old-age population is more susceptible to knee-related musculoskeletal disorders such as arthritis, ultimately driving the market growth. Moreover, the rising prevalence of Osteoarthritis (OA) and different types of disabilities are also expected to support the market’s growth. Osteoarthritis is associated with aging and is more common among people with other chronic conditions, such as heart disease, diabetes, and obesity. 

Furthermore, the integration of new and advanced technologies such as Artificial Intelligence (AI) and Robotics in Foot Drop surgical procedures, ongoing research activities, and an increase in R&D expenditure along with recent product launches is expected to boost the global Foot Drop Treatment Devices market.

However, despite several favorable factors, some of the key aspects, such as side effects associated with prolonged usage and fitting-related issues, may restrict the foot drop treatment devices’ market growth in the coming years.

The outbreak of the COVID-19 infection has severely impacted the Foot Drop Treatment Devices market growth. To contain the spread of COVID infections and to save human lives from novel coronavirus, governments worldwide have introduced several precautionary measures such as lockdowns and strict social distancing policies. The COVID-19-affected patients were given utmost priority compared to people with other diseases and disorders, impacting the Foot Drop Treatment Devices demand. The lockdowns measure has further disrupted the supply chain, limiting production distribution and the availability of products globally.

Get a sneak peek at the evolving market dynamics and key trends @ Foot Drop Treatment Devices Market Dynamics Analysis

Report Metrics Details
Coverage Global
Study Period 2019–2027
Base Year  2021
Market CAGR 8.15%
Key Foot Drop Treatment Devices Companies Ottobock, Bioness Inc., AxioBionics, Accelerated Care Plus Corporation, Saebo, Inc., Boston Orthotics & Prosthetics, Turbomed Orthotics, Össur, Thrive Orthopedics, Allard USA Inc., NextStep Robotics, Finetech Medical, Arthrex, Inc., Evolution Devices, Narang Medical Limited, SCHECK & SIRESS, AliMed, The London Orthotics Consultancy Ltd, Access Prosthetics, Spinal Solutions, and others

Foot Drop Treatment Devices Market Assessment 

  • Market Segmentation –
    • By Product Type – Electrical Stimulator, Braces/Splints 
    • By Application – Neuropathy, Muscle Disorders, Brain & Spinal Disorders, Others
    • End-User – Hospitals & Clinics, Ambulatory Surgical Centers, and Others
    • Geography – North America, Europe, Asia-Pacific, and Rest of the World
  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players are set to emerge as the trendsetter in the market @ Foot Drop Treatment Devices Companies

Table of Contents 

1 Report Introduction
2 Executive summary
3 Regulatory and Patent Analysis
4 Key Factors Analysis
5 Porter’s Five Forces Analysis
6 COVID-19 Impact Analysis on Foot Drop Treatment Devices Market
7 Foot Drop Treatment Devices Market Layout
8 Global Company Share Analysis – Key 3-5 Companies
9 Foot Drop Treatment Devices Market Company and Product Profiles
10 Project Approach
11 About DelveInsight

Interested in knowing how the market will grow by 2027? Click to get a snapshot of the Foot Drop Treatment Devices Market Research

Related Reports

Diabetic Foot Ulcers Market

“Diabetic Foot Ulcers Market Outlook 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends in the seven major market, i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key companies in the Diabetic Foot Ulcers Market include Amniox/TissueTech, Helixmith, Oneness Biotech, Rheacell/Ticeba, Lakewood-Amedex, Aurealis Therapeutics, Biotherapy Services, Microbion Corporation, Mallinckrodt, and others. 

Athlete’s Foot Market 

“Athlete’s Foot Market Outlook 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends in the seven major markets, i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key companies in the Athlete’s Foot Market include Bausch Health, Dembiont, Blueberry Therapeutics, Novan, and others.

Multiple Sclerosis Market

“Multiple Sclerosis Market Outlook 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends in the seven major markets, i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key companies in the Multiple Sclerosis Market include Immune Response BioPharma, Inc., Clene Nanomedicine, Sanofi, Merck Healthcare KGaA, TG Therapeutics, Inc., Apimeds Inc., Bayer HealthCare, Novartis, Biogen, Alkermes, Genentech, and others. 

Plantar Fasciitis Market 

“Plantar Fasciitis Market Outlook 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends in the seven major markets, i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key companies in the Plantar Fasciitis Market include Mimedx, Revance Therapeutics, and others. 

Venous Leg Ulcer Market 

“Venous Leg Ulcer Market Outlook 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends in the seven major markets, i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key companies in the Plantar Fasciitis Market include Reponex Pharmaceuticals, Energenesis Biomedical, MediWound, Solascure limited, TR Therapeutics, Promore Pharma AB, NovaLead Pharma, RHEACELL, and others.

Other Trending Reports

Goitre MarketThymus Cancer Market | US Healthcare Outlook Report | Venous Stenosis Market | Negative Pressure Wound Therapy Systems Market | Global Kinase Inhibitor in Autoimmune Diseases Market | Metrorrhagia Market | Dysfunctional Uterine Bleeding Market | Hypereosinophilic Syndrome Market | Age-related Vision Dysfunction Market | Dental Lasers Market | CRISPR Therapies Pipeline Insight | Cell And Gene Therapy For Multiple Myeloma Market | Drug Hypersensitivity Market | Dysthymia Market | Persistent Depressive Disorder Market | Cancer Vaccines Market | Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Market | Substance use disorder Market | Idiopathic Thrombocytopenic Purpura Market | Spinal Fusion Devices Market | Atherectomy Devices Market | Prosthetic Heart Valve Market | Cardiac Monitoring System Market | Chemotherapy-induced nausea and vomiting (CINV) Market | Diabetes Market | Ocular Melanoma Market | Breast Pumps Market | Stereotactic Surgery Devices Market  Atopic Dermatitis Market | Concussions Market | Osteoporosis Market | Myelofibrosis (MF) Market | Cancer Cachexia (CC) Market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

CONTACT: Contact Us Shruti Thakur  [email protected] +1(919)321-6187  https://www.delveinsight.com/medical-devices

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Mango Bunch takes no editorial responsibility for the same.